Actual Medicinal Product (AMP) Olanzapine 20mg tablets (Kent Pharma (UK) Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Protect from light. Protect from moisture. Manufacturer recommends storing in original container.
Olanzapine may be irritant to the skin and eyes, so take precautions to avoid contact such as wear gloves. - Provenance
-
This recommendation is based on the products Zyprexa 20mg coated tablets (Neon Healthcare Ltd) and Olanzapine 20mg tablets (Krka UK Ltd).
- Generic
- Olanzapine
- Formulation
- Olanzapine 20mg tablets
-
Olanzapine
-
Olanzapine 20mg tablets
-
Olanzapine 20mg tablets (Kent Pharma (UK) Ltd)
-
-
Olanzapine 10mg oral lyophilisates sugar free
Olanzapine 10mg orodispersible tablets sugar free